tiprankstipranks
Trending News
More News >
NexgenRx Inc (TSE:NXG)
:NXG
Canadian Market

NexgenRx (NXG) Income Statement

Compare
18 Followers

NexgenRx Income Statement

Last quarter (Q3 2024), NexgenRx's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, NexgenRx's net income was $149.23K. See NexgenRx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 10.82M$ ―$ 9.81M$ 9.67M$ 8.37M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.31M$ 1.41M$ 1.33M$ 936.99K$ 832.75K
EBITDA
$ 1.15M$ ―$ 3.40M$ 2.96M$ 815.97K
Operating Income
$ -143.88K$ ―$ 2.20M$ 2.16M$ 93.52K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -331.97K$ ―$ 4.02M$ 2.12M$ -207.94K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

NexgenRx Earnings and Revenue History